Powerful biophysical and structural biology tools enable the study of large numbers of fragments and are opening up new possibilities in the treatment of various diseases. Here we report the results of a conventional and a covalent Fragment Screening and show how orthogonal biophysical and structural methods enable rapid identification, characterization, and optimization of fragments.
Key Learning Objectives:
- Covalent & Conventional FBDD as an Integrated Service in Wuxi Biology
- Available Fragment Libraries
- Established Screening Workflow & Screening Technologies
- Structure Determination for Fragments
- Hit Expansion & Med Chem Capabilities
- Case Studies to Highlight Capabilities
Who Should Attend:
- CSO, Senior Scientist, MedChem experts & all scientist interested in FBDD as well as discovery of covalent inhibitors